BioCryst to Present at Upcoming Investor Conferences

About this update from Biocryst Pharmaceuticals, Inc.

RESEARCH TRIANGLE PARK, N.C. , May 27, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company plans to present at the following conferences: Jefferies Global Healthcare Conference in New York on Wednesday, June 4, 2025 , at 4:55 p.m. ET . Goldman Sachs 46th Annual Global Healthcare Conference in Miami on Monday, June 9, 2025 , at 8:40 a.m. ET . Links to the live audio webcasts and replays of the presentations may be accessed in the Investors & Media section of BioCryst’s website at www.biocryst.com . About BioCryst Pharmaceuticals BioCryst Pharmaceuticals is a global biotechnology company with a deep commitment to improving the lives of people living with hereditary angioedema and other rare diseases. BioCryst leverages its expertise in structure-guided drug design to develop first-in-class or best-in-class oral small-molecule and protein therapeutics to target difficult-to-treat diseases. BioCryst has commercialized ORLADEYO® (berotralstat), the first oral, once-daily plasma kallikrein inhibitor, and is advancing a pipeline of small-molecule and protein therapies. For more information, please visit www.biocryst.com or follow us on LinkedIn . BCRXW Contact : John Bluth +1 919 859 7910 [email protected] Source: BioCryst Pharmaceuticals, Inc.

View stock analysis, news, and events for Biocryst Pharmaceuticals, Inc.